FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Former ACRA Taylor Moves to BIO

[ Price : $8.95]

Former FDA associate commissioner for regulatory affairs John Taylor III resigns his government affairs post at Abbott to join Bio...

FDA OKs Levaquin Expanded Indication

[ Price : $8.95]

FDA approves Ortho-McNeils Levaquin 750 mg intravenous and oral use under a five-day, once-daily regimen for treating complicated ...

CU Challenges White House on Drug Trial Results

[ Price : $8.95]

Consumers Union says White House opposition to requiring drug companies to make trial results public is shocking.

Info on PMA Approval Sent to OMB

[ Price : $8.95]

Federal Register Notice: FDA submits a proposed collection of information on premarket approval of medical devices to the Office o...

Comments Reopened on IVD Assay Guidance

[ Price : $8.95]

Federal Register Notice: FDA reopens the comment period for a draft guidance on in vitro diagnostic multivariate index assays.

Guidance on Commercial Analyte Specific Reagents

[ Price : $8.95]

Federal Register Notice: FDA releases a guidance on frequently asked questions for commercially distributed analyte specific reage...

FDA Accepts Medicines Co NDA for Cleviprex

[ Price : $8.95]

FDA accepts a Medicines Co. NDA for Cleviprex, an intravenous formulation indicated for treating acute hypertension.

Online Consumers Like Behavioral Ads

[ Price : $8.95]

Revenue Science says online consumers are more responsive to behaviorally targeted ads than to contextual ads.

FDA Approves New Evista Breast Cancer Indication

[ Price : $8.95]

FDA approves Lillys Evista for two breast cancer indications in postmenopausal women.

Hospira Experiencing Shortage of A-Methapred

[ Price : $8.95]

FDA says Hospira is experiencing a shortage of A-Methapred injection 125 mg vials due to manufacturing delays.